These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 19945406)
1. Prevention of steatosis by hepatic JNK1. Sabio G; Cavanagh-Kyros J; Ko HJ; Jung DY; Gray S; Jun JY; Barrett T; Mora A; Kim JK; Davis RJ Cell Metab; 2009 Dec; 10(6):491-8. PubMed ID: 19945406 [TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522 [TBL] [Abstract][Full Text] [Related]
3. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. Zhang QY; Zhao LP; Tian XX; Yan CH; Li Y; Liu YX; Wang PX; Zhang XJ; Han YL Hepatology; 2017 Sep; 66(3):834-854. PubMed ID: 28508477 [TBL] [Abstract][Full Text] [Related]
4. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Sabio G; Das M; Mora A; Zhang Z; Jun JY; Ko HJ; Barrett T; Kim JK; Davis RJ Science; 2008 Dec; 322(5907):1539-43. PubMed ID: 19056984 [TBL] [Abstract][Full Text] [Related]
5. cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Sabio G; Davis RJ Trends Biochem Sci; 2010 Sep; 35(9):490-6. PubMed ID: 20452774 [TBL] [Abstract][Full Text] [Related]
6. Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism. Belgardt BF; Mauer J; Wunderlich FT; Ernst MB; Pal M; Spohn G; Brönneke HS; Brodesser S; Hampel B; Schauss AC; Brüning JC Proc Natl Acad Sci U S A; 2010 Mar; 107(13):6028-33. PubMed ID: 20231445 [TBL] [Abstract][Full Text] [Related]
7. Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice. Yu XX; Murray SF; Watts L; Booten SL; Tokorcheck J; Monia BP; Bhanot S Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E436-45. PubMed ID: 18523126 [TBL] [Abstract][Full Text] [Related]
8. JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage. Becattini B; Zani F; Breasson L; Sardi C; D'Agostino VG; Choo MK; Provenzani A; Park JM; Solinas G FASEB J; 2016 Sep; 30(9):3124-32. PubMed ID: 27230858 [TBL] [Abstract][Full Text] [Related]
9. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Sabio G; Kennedy NJ; Cavanagh-Kyros J; Jung DY; Ko HJ; Ong H; Barrett T; Kim JK; Davis RJ Mol Cell Biol; 2010 Jan; 30(1):106-15. PubMed ID: 19841069 [TBL] [Abstract][Full Text] [Related]
10. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. Gao Z; Zhang J; Kheterpal I; Kennedy N; Davis RJ; Ye J J Biol Chem; 2011 Jun; 286(25):22227-34. PubMed ID: 21540183 [TBL] [Abstract][Full Text] [Related]
11. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid. Yang YM; Seo SY; Kim TH; Kim SG Hepatology; 2012 Dec; 56(6):2209-20. PubMed ID: 22807119 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Singh R; Wang Y; Xiang Y; Tanaka KE; Gaarde WA; Czaja MJ Hepatology; 2009 Jan; 49(1):87-96. PubMed ID: 19053047 [TBL] [Abstract][Full Text] [Related]
14. Role of the hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Sabio G; Cavanagh-Kyros J; Barrett T; Jung DY; Ko HJ; Ong H; Morel C; Mora A; Reilly J; Kim JK; Davis RJ Genes Dev; 2010 Feb; 24(3):256-64. PubMed ID: 20080940 [TBL] [Abstract][Full Text] [Related]